Early Leukapheresis Depletion in an Ex-Premature with Severe Acute Respiratory Distress Syndrome Due to Bordetella Pertussis and Coronavirus Infection
Author(s) -
Emanuele Rossetti,
Linda Appierto,
Antonella Meschini,
Giovanna Leone,
Stefania Lazzaro,
Giovanna Del Principe,
Roberto Bianchi,
Sergio Picardo
Publication year - 2020
Publication title -
blood purification
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 57
eISSN - 1421-9735
pISSN - 0253-5068
DOI - 10.1159/000507873
Subject(s) - medicine , leukocytosis , respiratory distress , ards , leukapheresis , bordetella pertussis , mechanical ventilation , pediatric intensive care unit , pediatrics , intensive care medicine , immunology , anesthesia , lung , stem cell , biology , cd34 , bacteria , genetics
We describe a 2 weeks corrected gestational age infant admitted in pediatric intensive care unit (PICU) for severe acute respiratory distress syndrome (ARDS) associated to Bordetella pertussis and Coronavirus infection. He developed leukocytosis as soon as ARDS required intubation and aggressive mechanical ventilation: hence he underwent 3 early therapeutic leukapheresis treatments in order to avoid the worsening of related cardiopulmonary complications, according to recent literature on pertussis infection in infants. The infant was discharged from PICU healthy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom